ArticleCureus2026
Fibrodysplasia Ossificans Progressiva: A Case Report From the UAE.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare autosomal dominant disorder characterized by congenital malformation of the great toes and progressive heterotopic ossification of soft tissues, caused by mutations in the ACVR1 gene. Flare-ups are painful inflammatory episodes that may occur spontaneously or following minor trauma. The estimated incidence is rare, and to our knowledge, a genetically unconfirmed case has previously been reported in the United Arab Emirates. We report a 15-year-old Sudanese girl with genetically confirmed FOP, diagnosed at two years of age. She initially presented in infancy with painful shoulder restriction, followed by recurrent trauma- and infection-triggered flare-ups. Progressive heterotopic ossification led to jaw ankylosis, hip involvement with gait impairment, and eventual wheelchair dependence. During her most recent admission, she presented with painful right forearm swelling that was managed as cellulitis; this was later recognized as an FOP flare-up. Corticosteroid therapy was not initiated because she presented six days after symptom onset, whereas current recommendations support administration within 24 hours of flare-up onset. Management has primarily consisted of supportive care, physiotherapy for mobility preservation, and family education focused on trigger avoidance and early presentation to medical care at the onset of known flare-ups. To our knowledge, this case represents the first genetically confirmed reported case of FOP in the region. It underscores the importance of early recognition of flare-ups and timely presentation to optimize management and improve patient education in this rare condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.